Centronuclear Myopathy Clinical Trial
Official title:
A Prospective, Longitudinal Study of the Natural History and Functional Status of Patients With Centronuclear Myopathies
This is a prospective, longitudinal study of the natural disease course intended to recruit approximately 60 patients with centronuclear myopathies (CNM) in Europe and the United States. The duration of the study, including the enrollment period, will be approximately 4 years. Data from the study will be used to characterize the natural disease course of CNM, to identify prognostic variables of the disease and to determine the best outcome measure(s) for the evaluation of future therapeutic approaches.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Enrolling by invitation |
NCT05099107 -
Changes of Motor Function Tests in Congenital Myopathy Subjects Treated With Oral Salbutamol as Compared to no Treatment
|
N/A | |
| Completed |
NCT03351270 -
Prospective Natural History Study of Patients With Myotubular Myopathy and Other CentroNuclear Myopathies
|
N/A | |
| Recruiting |
NCT04064307 -
Myotubular and Centronuclear Myopathy Patient Registry
|
||
| Recruiting |
NCT05982119 -
Assessments in Patients With Muscular Pathology and in Control Subjects : The ActiLiège Next Study
|
N/A | |
| Terminated |
NCT04033159 -
Early Phase Human Drug Trial to Investigate Dynamin 101 (DYN101) in Patients ≥ 16 Years With Centronuclear Myopathies
|
Phase 1/Phase 2 | |
| Withdrawn |
NCT04743557 -
Early Phase Human Drug Trial to Investigate DYN101 in Participants 2 to 17 Years With Centronuclear Myopathies
|
Phase 1/Phase 2 | |
| Not yet recruiting |
NCT06157268 -
The Natural History and Muscle Fatigability of Patients With Congenital Myopathies.
|
||
| Recruiting |
NCT00272883 -
Molecular and Genetic Studies of Congenital Myopathies
|